Invesco’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,038
| Closed | -$26.2K | – | 3811 |
|
|
2025
Q1 | $26.2K | Sell |
58,038
-3,747
| -6% | -$1.69K | ﹤0.01% | 3721 |
|
|
2024
Q4 | $31K | Buy |
61,785
+1,272
| +2% | +$639 | ﹤0.01% | 3710 |
|
|
2024
Q3 | $54.8K | Buy |
60,513
+3,749
| +7% | +$3.39K | ﹤0.01% | 3659 |
|
|
2024
Q2 | $56.6K | Buy |
56,764
+15
| +0% | +$15 | ﹤0.01% | 3797 |
|
|
2024
Q1 | $84K | Sell |
56,749
-130
| -0.2% | -$192 | ﹤0.01% | 3747 |
|
|
2023
Q4 | $62K | Sell |
56,879
-9,013
| -14% | -$9.82K | ﹤0.01% | 3725 |
|
|
2023
Q3 | $77.8K | Hold |
65,892
| – | – | ﹤0.01% | 3741 |
|
|
2023
Q2 | $92.9K | Buy |
+65,892
| New | +$92.9K | ﹤0.01% | 3726 |
|
|
2022
Q2 | – | Sell |
-34,518
| Closed | -$53K | – | 4061 |
|
|
2022
Q1 | $53K | Sell |
34,518
-7,765
| -18% | -$11.9K | ﹤0.01% | 3890 |
|
|
2021
Q4 | $103K | Sell |
42,283
-13,360
| -24% | -$32.5K | ﹤0.01% | 3861 |
|
|
2021
Q3 | $140K | Buy |
55,643
+11,196
| +25% | +$28.2K | ﹤0.01% | 3845 |
|
|
2021
Q2 | $126K | Buy |
+44,447
| New | +$126K | ﹤0.01% | 3834 |
|
|
2019
Q1 | – | Sell |
-33,796
| Closed | -$31K | – | 3708 |
|
|
2018
Q4 | $31K | Buy |
33,796
+299
| +0.9% | +$274 | ﹤0.01% | 3683 |
|
|
2018
Q3 | $79K | Sell |
33,497
-5,484
| -14% | -$12.9K | ﹤0.01% | 3750 |
|
|
2018
Q2 | $80K | Sell |
38,981
-67,610
| -63% | -$139K | ﹤0.01% | 3750 |
|
|
2018
Q1 | $287K | Sell |
106,591
-4,226
| -4% | -$11.4K | ﹤0.01% | 3504 |
|
|
2017
Q4 | $238K | Sell |
110,817
-1,657
| -1% | -$3.56K | ﹤0.01% | 3498 |
|
|
2017
Q3 | $319K | Sell |
112,474
-671
| -0.6% | -$1.9K | ﹤0.01% | 3435 |
|
|
2017
Q2 | $356K | Buy |
+113,145
| New | +$356K | ﹤0.01% | 3430 |
|
|
2015
Q3 | – | Sell |
-1,326
| Closed | -$5K | – | 3869 |
|
|
2015
Q2 | $5K | Buy |
+1,326
| New | +$5K | ﹤0.01% | 4204 |
|